Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Hongjing Xia

Hongjing Xia

Principal Scientist Novartis

Seminars

Monday 20th July 2026

Impact of mRNA Design on In Vivo Murine mRNA-LNP CD19 CAR in a Syngeneic Mouse Model

1:30 pm

More Information to Come Soon!

Hongjing Xia

View all Speakers

View Event Brochure